Literature DB >> 12065790

Carcinoma of the anus: strategies in management.

Natia Esiashvili1, Jerome Landry, Richard H Matthews.   

Abstract

The management of anal cancer underwent an interesting transformation over the last two decades. Prior to this period, the standard definitive treatment for carcinoma of the anal canal was abdominal-perineal resection, which necessitated a permanent colostomy. The organ preservation concept appeared following the discovery of a high complete response rate from preoperative combined chemoradiation prior to abdominal-perineal resection. The organ preservation method of treatment rapidly gained popularity and ultimately saved a large number of patients from undergoing abdominal-perineal resection and colostomy. Chemoradiation treatment itself subsequently went through an evolutionary process. Several studies have sought to define the optimal chemotherapeutic regimen as well as radiation treatment dose and fractionation. Ongoing studies attempt to define an optimal treatment regimen that yields a higher cure rate while minimizing toxicity. We review the etiology, epidemiology, and treatment regimens for anal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12065790     DOI: 10.1634/theoncologist.7-3-188

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  10 in total

Review 1.  Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).

Authors:  Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

2.  Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.

Authors:  V Dell'Acqua; J Kobiela; F Kraja; M C Leonardi; A Surgo; M A Zerella; S Arculeo; C Fodor; R Ricotti; M G Zampino; S Ravenda; G Spinoglio; R Biffi; A Bazani; R Luraschi; S Vigorito; P Spychalski; R Orecchia; R Glynne-Jones; B A Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-03-28       Impact factor: 3.064

3.  Reconstruction of the perineum following anorectal cancer excision.

Authors:  Nicola Petrie; Graham Branagan; Caroline McGuiness; Shaun McGee; Clare Fuller; Helen Chave
Journal:  Int J Colorectal Dis       Date:  2008-08-08       Impact factor: 2.571

4.  Surgical salvage therapy of anal cancer.

Authors:  Yue-Kui Bai; Wen-Lan Cao; Ji-Dong Gao; Jun Liang; Yong-Fu Shao
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

5.  Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice.

Authors:  Roderich E Schwarz
Journal:  World J Surg Oncol       Date:  2007-03-13       Impact factor: 2.754

Review 6.  Assessing the order of magnitude of outcomes in single-arm cohorts through systematic comparison with corresponding cohorts: an example from the AMOS study.

Authors:  Harald J Hamre; Anja Glockmann; Wilfried Tröger; Gunver S Kienle; Helmut Kiene
Journal:  BMC Med Res Methodol       Date:  2008-03-19       Impact factor: 4.615

7.  Clinicopathologic Features and Outcome of Adenocarcinoma of the Anal Canal: A Population-Based Study.

Authors:  Shekhar Gogna; Roberto Bergamaschi; Agon Kajmolli; Mahir Gachabayov; Aram Rojas; David Samson; Rifat Latifi; Xiang Da Dong
Journal:  Int J Surg Oncol       Date:  2020-05-13

8.  Combined bias suppression in single-arm therapy studies.

Authors:  Harald J Hamre; Anja Glockmann; Gunver S Kienle; Helmut Kiene
Journal:  J Eval Clin Pract       Date:  2008-03-24       Impact factor: 2.431

9.  Anal canal carcinoma: experience from a single Korean institution.

Authors:  Won-Suk Lee; Ho-Kyung Chun; Woo Yong Lee; Seong Hyeon Yun; Haeran Yun; Yong Beom Cho; Won-Ki Kang; Young-Suk Park; Seung-Jae Huh; Yong Chan Ahn; Won Park
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

10.  Carcinoma of the anal canal: Intensity modulated radiation therapy (IMRT) versus three-dimensional conformal radiation therapy (3DCRT).

Authors:  Charlotte Sale; Phillip Moloney; Maitham Mathlum
Journal:  J Med Radiat Sci       Date:  2013-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.